Trastuzumab in combination with gemcitabine and vinorelbine as second-line therapy for HER-2/neu overexpressing metastatic breast cancer.
about
The role of HER2-targeted therapies in women with HER2-overexpressing metastatic breast cancerEfficacy of trastuzumab in routine clinical practice and after progression for metastatic breast cancer patients: the observational Hermine study.Phase I and II Study of Gemcitabine and Vinorelbine in Heavily Pretreated Patients with Metastatic Breast Cancer and Review of the Literature.
P2860
Trastuzumab in combination with gemcitabine and vinorelbine as second-line therapy for HER-2/neu overexpressing metastatic breast cancer.
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Trastuzumab in combination wit ...... sing metastatic breast cancer.
@ast
Trastuzumab in combination wit ...... sing metastatic breast cancer.
@en
type
label
Trastuzumab in combination wit ...... sing metastatic breast cancer.
@ast
Trastuzumab in combination wit ...... sing metastatic breast cancer.
@en
prefLabel
Trastuzumab in combination wit ...... sing metastatic breast cancer.
@ast
Trastuzumab in combination wit ...... sing metastatic breast cancer.
@en
P2093
P1433
P1476
Trastuzumab in combination wit ...... sing metastatic breast cancer.
@en
P2093
Cristian Massaccesi
Domenico Gattuso
Francesco Torino
Giampietro Gasparini
Guido Carillio
Livia De Sio
Luigi Mariani
Massimo Fanelli
Maurizio Bonsignori
Paola Bonginelli
P304
P577
2006-08-01T00:00:00Z